Paratek Pharma Inc
(PRTK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,910 | -59,084 | -26,831 | -8,629 | -18,346 |
| Depreciation Amortization | 144 | 391 | 312 | 225 | 110 |
| Accounts receivable | 4,234 | -21,785 | -9,368 | -46,618 | -240 |
| Other Working Capital | -5,334 | -8,189 | -12,423 | -53,594 | -5,216 |
| Other Operating Activity | -244 | 40,394 | 19,845 | 53,892 | 2,174 |
| Operating Cash Flow | $-19,110 | $-48,273 | $-28,465 | $-54,724 | $-21,518 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -15,160 | 4,883 | 20,000 | 20,000 | 20,000 |
| PPE Investments | -36 | -373 | -373 | -379 | -262 |
| Investing Cash Flow | $-15,196 | $4,510 | $19,627 | $19,621 | $19,738 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | -716 | -397 | -397 | -397 |
| Common Stock Issued | 3,097 | 19,048 | 14,436 | 5,000 | 3 |
| Financing Cash Flow | $3,097 | $18,332 | $14,039 | $4,603 | $-394 |
| Beginning Cash Position | 80,617 | 106,048 | 106,048 | 106,048 | 106,048 |
| End Cash Position | 49,408 | 80,617 | 111,249 | 75,548 | 103,874 |
| Net Cash Flow | $-31,209 | $-25,431 | $5,201 | $-30,500 | $-2,174 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,110 | -48,273 | -28,465 | -54,724 | -21,518 |
| Capital Expenditure | -36 | -373 | -373 | -379 | -262 |
| Free Cash Flow | -19,146 | -48,646 | -28,838 | -55,103 | -21,780 |